Yan Wang

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Antonio Passaro, Jing Wang, Yan Wang et al. · Annals of Oncology · 2023 · 396 citations · Full text

Medicine, Oncology, Pharmacology +17

The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer

Weigang Wang, Xiaoqin Xu, Yan Wang et al. · Clinica Chimica Acta · 2017 · 205 citations

Medicine, Oncology, Pathology +16

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)

Jianming Xu, Yi Li, Qingxia Fan et al. · Nature Communications · 2022 · 150 citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis

Yan Wang, Yina Li, Pingrun Chen et al. · Annals of Translational Medicine · 2019 · 107 citations · Full text

Medicine, Immunology, Oncology +16

Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis

Liangping Xia, Yan Wang, Shaodong Hong et al. · PLoS ONE · 2016 · 72 citations · Full text

Medicine, Nutritional Sciences, Oncology +15